Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “RESPIRATORY TRACT DISEASES”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 847 records · Page 47Linked to original sources
PubMed1982

[Therapy of obstructive respiratory tract diseases with pure theophylline retard].

In an open study 19 patients with chronic obstructive lung disease were treated over nine days with Afonilum retard (1 capsule contains 250 mg pure theophylline in retard pellets form, the mite-form contains 125 mg pure theophylline in retard pellets form). Vital capacity (VC), forced expiratory volume (FEV1) and bronchial resistance (Rt) were measured before and on the third, sixth, and ninth day at eight o'clock and four hours later. Theophylline serum levels were measured by radioimmunoassay. In 14 patients 2 capsules (250 mg theophylline twice a day) were administered in twelve hours intervals. In this group lung function improved statistically significantly (p less than 0.01) for VC to 37%, FEV1 to 80% and Rt to 64% in comparison to the values before. Mean values of theophylline serum concentrations were 6.9 +/- 2.1 micrograms/ml at eight o'clock before the morning dose and 9.6 +/- 2.2 micrograms/ml four hours later on the ninth day. In five patients 375 mg theophylline were administered twice a day from third day on. In this group lung function improved for VC to 50%, FEV1 to 75% and Rt to 61% compared with the values before. Mean values of theophylline serum concentrations resulted in 10.8 +/- 3.6 micrograms/ml at eight o'clock before the morning dose and in 15.0 +/- 3.5 four hours later on the ninth day.

Asthma↗